MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$345,910K
(-47.62%↓ Y/Y)
Interest income
$26,828K
(-36.04%↓ Y/Y)
Foreign exchange gain
(loss)
$1,348K
(226.69%↑ Y/Y)
Loss before income
taxes
-$344,894K
(-44.66%↓ Y/Y)
Income tax recovery
(expense) (note 14)
$1,016K
(124.85%↑ Y/Y)
Total other income
$28,176K
(-31.07%↓ Y/Y)
Loss from operations
-$373,070K
(-33.57%↓ Y/Y)
Collaboration revenue (note
10)
$7,500K
Total operating
expenses
$380,570K
(36.26%↑ Y/Y)
Research and development
$300,938K
(43.04%↑ Y/Y)
General and
administrative
$79,632K
(15.57%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)